APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biomolecule Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Biomolecule Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026199 pages

Choose your research edition.

Industry ResearchBiomolecule Software Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Biomolecule Software Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Biomolecule Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biomolecule Software Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Biomolecule Software Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global Biomolecule Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Biomolecule Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Biomolecule Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomolecule Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Biomolecule Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Biomolecule Software include Hamilton Thorne, Hermes Medical Solutions, Inc, INDICAL BIOSCIENCE, lexogen, Repligen, SCC SOFT COMPUTER, Oxford Instruments, Partek, Inc. and Stilla Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Biomolecule Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Biomolecule Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biomolecule Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biomolecule Software market size, projected growth trends, production technologies, key applications, and end-use industries.

Biomolecule Software Segment by Company

Hamilton Thorne

Hermes Medical Solutions, Inc

INDICAL BIOSCIENCE

lexogen

Repligen

SCC SOFT COMPUTER

Oxford Instruments

Partek, Inc.

Stilla Technologies

Vela Diagnostics

Vittoriobasurto

SCIEX

SoftGenetics, LLC.

Benchling

BioSistemika

CapitalBio Technology

cytena GmbH

Eppendorf SE

GenomSys

Mission Bio

Multid Analyses AB

PhenoSystems SA

Progenie Molecular

Biomolecule Software Segment by Type

Windows

Linux

MacOS

Biomolecule Software Segment by Application

Hospital

Clinic

Research Center

Biomolecule Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomolecule Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomolecule Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomolecule Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biomolecule Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomolecule Software industry.

Chapter 3: Detailed analysis of Biomolecule Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomolecule Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biomolecule Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Windows Table 3. Key Players of Linux Table 4. Key Players of MacOS Table 4. Global Biomolecule Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Research Center Table 8. Global Biomolecule Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Biomolecule Software Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Biomolecule Software Market Share by Region (2021-2026) Table 11. Global Biomolecule Software Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Biomolecule Software Market Share by Region (2027-2032) Table 13. Biomolecule Software Industry Trends Table 14. Biomolecule Software Industry Drivers Table 15. Biomolecule Software Industry Opportunities and Challenges Table 16. Biomolecule Software Industry Restraints Table 17. Global Biomolecule Software Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Biomolecule Software Revenue Market Share by Company (2021-2026) Table 19. Global Biomolecule Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biomolecule Software Key Company Head Office and Area Served Table 21. Global Biomolecule Software Company, Product Type & Application Table 22. Global Biomolecule Software Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Biomolecule Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Biomolecule Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biomolecule Software Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Biomolecule Software Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Biomolecule Software Revenue Market Share by Type (2021-2026) Table 29. Global Biomolecule Software Revenue Market Share by Type (2027-2032) Table 30. Global Biomolecule Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biomolecule Software Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Biomolecule Software Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Biomolecule Software Revenue Market Share by Application (2021-2026) Table 34. Global Biomolecule Software Revenue Market Share by Application (2027-2032) Table 35. Hamilton Thorne Company Information Table 36. Hamilton Thorne Business Overview Table 37. Hamilton Thorne Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Hamilton Thorne Biomolecule Software Product Portfolio Table 39. Hamilton Thorne Recent Development Table 40. Hermes Medical Solutions, Inc Company Information Table 41. Hermes Medical Solutions, Inc Business Overview Table 42. Hermes Medical Solutions, Inc Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Hermes Medical Solutions, Inc Biomolecule Software Product Portfolio Table 44. Hermes Medical Solutions, Inc Recent Development Table 45. INDICAL BIOSCIENCE Company Information Table 46. INDICAL BIOSCIENCE Business Overview Table 47. INDICAL BIOSCIENCE Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. INDICAL BIOSCIENCE Biomolecule Software Product Portfolio Table 49. INDICAL BIOSCIENCE Recent Development Table 50. lexogen Company Information Table 51. lexogen Business Overview Table 52. lexogen Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. lexogen Biomolecule Software Product Portfolio Table 54. lexogen Recent Development Table 55. Repligen Company Information Table 56. Repligen Business Overview Table 57. Repligen Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Repligen Biomolecule Software Product Portfolio Table 59. Repligen Recent Development Table 60. SCC SOFT COMPUTER Company Information Table 61. SCC SOFT COMPUTER Business Overview Table 62. SCC SOFT COMPUTER Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. SCC SOFT COMPUTER Biomolecule Software Product Portfolio Table 64. SCC SOFT COMPUTER Recent Development Table 65. Oxford Instruments Company Information Table 66. Oxford Instruments Business Overview Table 67. Oxford Instruments Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Oxford Instruments Biomolecule Software Product Portfolio Table 69. Oxford Instruments Recent Development Table 70. Partek, Inc. Company Information Table 71. Partek, Inc. Business Overview Table 72. Partek, Inc. Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Partek, Inc. Biomolecule Software Product Portfolio Table 74. Partek, Inc. Recent Development Table 75. Stilla Technologies Company Information Table 76. Stilla Technologies Business Overview Table 77. Stilla Technologies Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Stilla Technologies Biomolecule Software Product Portfolio Table 79. Stilla Technologies Recent Development Table 80. Vela Diagnostics Company Information Table 81. Vela Diagnostics Business Overview Table 82. Vela Diagnostics Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Vela Diagnostics Biomolecule Software Product Portfolio Table 84. Vela Diagnostics Recent Development Table 85. Vittoriobasurto Company Information Table 86. Vittoriobasurto Business Overview Table 87. Vittoriobasurto Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Vittoriobasurto Biomolecule Software Product Portfolio Table 89. Vittoriobasurto Recent Development Table 90. SCIEX Company Information Table 91. SCIEX Business Overview Table 92. SCIEX Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. SCIEX Biomolecule Software Product Portfolio Table 94. SCIEX Recent Development Table 95. SoftGenetics, LLC. Company Information Table 96. SoftGenetics, LLC. Business Overview Table 97. SoftGenetics, LLC. Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. SoftGenetics, LLC. Biomolecule Software Product Portfolio Table 99. SoftGenetics, LLC. Recent Development Table 100. Benchling Company Information Table 101. Benchling Business Overview Table 102. Benchling Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. Benchling Biomolecule Software Product Portfolio Table 104. Benchling Recent Development Table 105. BioSistemika Company Information Table 106. BioSistemika Business Overview Table 107. BioSistemika Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. BioSistemika Biomolecule Software Product Portfolio Table 109. BioSistemika Recent Development Table 110. CapitalBio Technology Company Information Table 111. CapitalBio Technology Business Overview Table 112. CapitalBio Technology Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 113. CapitalBio Technology Biomolecule Software Product Portfolio Table 114. CapitalBio Technology Recent Development Table 115. cytena GmbH Company Information Table 116. cytena GmbH Business Overview Table 117. cytena GmbH Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 118. cytena GmbH Biomolecule Software Product Portfolio Table 119. cytena GmbH Recent Development Table 120. Eppendorf SE Company Information Table 121. Eppendorf SE Business Overview Table 122. Eppendorf SE Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 123. Eppendorf SE Biomolecule Software Product Portfolio Table 124. Eppendorf SE Recent Development Table 125. GenomSys Company Information Table 126. GenomSys Business Overview Table 127. GenomSys Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 128. GenomSys Biomolecule Software Product Portfolio Table 129. GenomSys Recent Development Table 130. Mission Bio Company Information Table 131. Mission Bio Business Overview Table 132. Mission Bio Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 133. Mission Bio Biomolecule Software Product Portfolio Table 134. Mission Bio Recent Development Table 135. Multid Analyses AB Company Information Table 136. Multid Analyses AB Business Overview Table 137. Multid Analyses AB Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 138. Multid Analyses AB Biomolecule Software Product Portfolio Table 139. Multid Analyses AB Recent Development Table 140. PhenoSystems SA Company Information Table 141. PhenoSystems SA Business Overview Table 142. PhenoSystems SA Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 143. PhenoSystems SA Biomolecule Software Product Portfolio Table 144. PhenoSystems SA Recent Development Table 145. Progenie Molecular Company Information Table 146. Progenie Molecular Business Overview Table 147. Progenie Molecular Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 148. Progenie Molecular Biomolecule Software Product Portfolio Table 149. Progenie Molecular Recent Development Table 150. North America Biomolecule Software Market Size by Type (2021-2026) & (US$ Million) Table 151. North America Biomolecule Software Market Size by Type (2027-2032) & (US$ Million) Table 152. North America Biomolecule Software Market Size by Application (2021-2026) & (US$ Million) Table 153. North America Biomolecule Software Market Size by Application (2027-2032) & (US$ Million) Table 154. North America Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 155. North America Biomolecule Software Market Size by Country (2021-2026) Table 156. North America Biomolecule Software Market Size by Country (2027-2032) Table 157. Europe Biomolecule Software Market Size by Type (2021-2026) & (US$ Million) Table 158. Europe Biomolecule Software Market Size by Type (2027-2032) & (US$ Million) Table 159. Europe Biomolecule Software Market Size by Application (2021-2026) & (US$ Million) Table 160. Europe Biomolecule Software Market Size by Application (2027-2032) & (US$ Million) Table 161. Europe Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Europe Biomolecule Software Market Size by Country (2021-2026) Table 163. Europe Biomolecule Software Market Size by Country (2027-2032) Table 164. China Biomolecule Software Market Size by Type (2021-2026) & (US$ Million) Table 165. China Biomolecule Software Market Size by Type (2027-2032) & (US$ Million) Table 166. China Biomolecule Software Market Size by Application (2021-2026) & (US$ Million) Table 167. China Biomolecule Software Market Size by Application (2027-2032) & (US$ Million) Table 168. Asia Biomolecule Software Market Size by Type (2021-2026) & (US$ Million) Table 169. Asia Biomolecule Software Market Size by Type (2027-2032) & (US$ Million) Table 170. Asia Biomolecule Software Market Size by Application (2021-2026) & (US$ Million) Table 171. Asia Biomolecule Software Market Size by Application (2027-2032) & (US$ Million) Table 172. Asia Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia Biomolecule Software Market Size by Country (2021-2026) Table 174. Asia Biomolecule Software Market Size by Country (2027-2032) Table 175. South America, Middle East & Africa Biomolecule Software Market Size by Type (2021-2026) & (US$ Million) Table 176. South America, Middle East & Africa Biomolecule Software Market Size by Type (2027-2032) & (US$ Million) Table 177. South America, Middle East & Africa Biomolecule Software Market Size by Application (2021-2026) & (US$ Million) Table 178. South America, Middle East & Africa Biomolecule Software Market Size by Application (2027-2032) & (US$ Million) Table 179. South America, Middle East & Africa Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. South America, Middle East & Africa Biomolecule Software Market Size by Country (2021-2026) Table 181. South America, Middle East & Africa Biomolecule Software Market Size by Country (2027-2032) Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Biomolecule Software Product Image Figure 2. Global Biomolecule Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Biomolecule Software Market Share by Type: 2025 VS 2032 Figure 4. Windows Image Figure 5. Linux Image Figure 6. MacOS Image Figure 7. Global Biomolecule Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Biomolecule Software Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Research Center Image Figure 12. Global Biomolecule Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 14. Global Biomolecule Software Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Biomolecule Software Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Biomolecule Software Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Biomolecule Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biomolecule Software Revenue Market Share by Type (2021-2032) Figure 21. Global Biomolecule Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Biomolecule Software Revenue Market Share by Application (2021-2032) Figure 23. North America Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 24. North America Biomolecule Software Market Share by Type (2021-2032) Figure 25. North America Biomolecule Software Market Share by Application (2021-2032) Figure 26. North America Biomolecule Software Market Share by Country (2021-2032) Figure 27. United States Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 28. Canada Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 30. Europe Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 31. Europe Biomolecule Software Market Share by Type (2021-2032) Figure 32. Europe Biomolecule Software Market Share by Application (2021-2032) Figure 33. Europe Biomolecule Software Market Share by Country (2021-2032) Figure 34. Germany Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 35. France Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 37. Italy Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 38. Russia Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 40. China Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 41. China Biomolecule Software Market Share by Type (2021-2032) Figure 42. China Biomolecule Software Market Share by Application (2021-2032) Figure 43. Asia Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 44. Asia Biomolecule Software Market Share by Type (2021-2032) Figure 45. Asia Biomolecule Software Market Share by Application (2021-2032) Figure 46. Asia Biomolecule Software Market Share by Country (2021-2032) Figure 47. Japan Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 51. India Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 52. Australia Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Biomolecule Software Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Biomolecule Software Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Biomolecule Software Market Share by Country (2021-2032) Figure 57. Brazil Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 62. UAE Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 64. Chile Biomolecule Software Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Windows
  • Linux
  • MacOS
Applications
  • Hospital
  • Clinic
  • Research Center
Companies covered
  • Hamilton Thorne
  • Hermes Medical Solutions, Inc
  • INDICAL BIOSCIENCE
  • lexogen
  • Repligen
  • SCC SOFT COMPUTER
  • Oxford Instruments
  • Partek, Inc.
  • Stilla Technologies
  • Vela Diagnostics
  • Vittoriobasurto
  • SCIEX
  • SoftGenetics, LLC.
  • Benchling
  • BioSistemika
  • CapitalBio Technology
  • cytena GmbH
  • Eppendorf SE
  • GenomSys
  • Mission Bio
  • Multid Analyses AB
  • PhenoSystems SA
  • Progenie Molecular

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Biomolecule Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Windows
  5. 1.2.3 Linux
  6. 1.2.4 MacOS
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Biomolecule Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Research Center
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Biomolecule Software Growth Trends by Region
  14. 1.5.1 Global Biomolecule Software Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Biomolecule Software Market Size by Region (2021-2026)
  16. 1.5.3 Biomolecule Software Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Biomolecule Software Market Dynamics
  1. 2.1 Biomolecule Software Industry Trends
  2. 2.2 Biomolecule Software Industry Drivers
  3. 2.3 Biomolecule Software Industry Opportunities and Challenges
  4. 2.4 Biomolecule Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Biomolecule Software Revenue by Company (2021-2026)
  2. 3.2 Global Biomolecule Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Biomolecule Software Key Company Head office and Area Served
  4. 3.4 Global Biomolecule Software Company, Product Type & Application
  5. 3.5 Global Biomolecule Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Biomolecule Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Biomolecule Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Biomolecule Software Tier 1, Tier 2, and Tier 3
4 Biomolecule Software Market by Type
  1. 4.1 Global Biomolecule Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Biomolecule Software Market Size by Type (2021-2032)
  3. 4.3 Global Biomolecule Software Market Size Share by Type (2021-2032)
5 Biomolecule Software Market by Application
  1. 5.1 Global Biomolecule Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Biomolecule Software Market Size by Application (2021-2032)
  3. 5.3 Global Biomolecule Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Hamilton Thorne
  2. 6.1.1 Hamilton Thorne Company Information
  3. 6.1.2 Hamilton Thorne Business Overview
  4. 6.1.3 Hamilton Thorne Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Hamilton Thorne Biomolecule Software Product Portfolio
  6. 6.1.5 Hamilton Thorne Recent Developments
  7. 6.2 Hermes Medical Solutions, Inc
  8. 6.2.1 Hermes Medical Solutions, Inc Company Information
  9. 6.2.2 Hermes Medical Solutions, Inc Business Overview
  10. 6.2.3 Hermes Medical Solutions, Inc Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Hermes Medical Solutions, Inc Biomolecule Software Product Portfolio
  12. 6.2.5 Hermes Medical Solutions, Inc Recent Developments
  13. 6.3 INDICAL BIOSCIENCE
  14. 6.3.1 INDICAL BIOSCIENCE Company Information
  15. 6.3.2 INDICAL BIOSCIENCE Business Overview
  16. 6.3.3 INDICAL BIOSCIENCE Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 INDICAL BIOSCIENCE Biomolecule Software Product Portfolio
  18. 6.3.5 INDICAL BIOSCIENCE Recent Developments
  19. 6.4 lexogen
  20. 6.4.1 lexogen Company Information
  21. 6.4.2 lexogen Business Overview
  22. 6.4.3 lexogen Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 lexogen Biomolecule Software Product Portfolio
  24. 6.4.5 lexogen Recent Developments
  25. 6.5 Repligen
  26. 6.5.1 Repligen Company Information
  27. 6.5.2 Repligen Business Overview
  28. 6.5.3 Repligen Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Repligen Biomolecule Software Product Portfolio
  30. 6.5.5 Repligen Recent Developments
  31. 6.6 SCC SOFT COMPUTER
  32. 6.6.1 SCC SOFT COMPUTER Company Information
  33. 6.6.2 SCC SOFT COMPUTER Business Overview
  34. 6.6.3 SCC SOFT COMPUTER Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 SCC SOFT COMPUTER Biomolecule Software Product Portfolio
  36. 6.6.5 SCC SOFT COMPUTER Recent Developments
  37. 6.7 Oxford Instruments
  38. 6.7.1 Oxford Instruments Company Information
  39. 6.7.2 Oxford Instruments Business Overview
  40. 6.7.3 Oxford Instruments Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Oxford Instruments Biomolecule Software Product Portfolio
  42. 6.7.5 Oxford Instruments Recent Developments
  43. 6.8 Partek, Inc.
  44. 6.8.1 Partek, Inc. Company Information
  45. 6.8.2 Partek, Inc. Business Overview
  46. 6.8.3 Partek, Inc. Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Partek, Inc. Biomolecule Software Product Portfolio
  48. 6.8.5 Partek, Inc. Recent Developments
  49. 6.9 Stilla Technologies
  50. 6.9.1 Stilla Technologies Company Information
  51. 6.9.2 Stilla Technologies Business Overview
  52. 6.9.3 Stilla Technologies Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Stilla Technologies Biomolecule Software Product Portfolio
  54. 6.9.5 Stilla Technologies Recent Developments
  55. 6.10 Vela Diagnostics
  56. 6.10.1 Vela Diagnostics Company Information
  57. 6.10.2 Vela Diagnostics Business Overview
  58. 6.10.3 Vela Diagnostics Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Vela Diagnostics Biomolecule Software Product Portfolio
  60. 6.10.5 Vela Diagnostics Recent Developments
  61. 6.11 Vittoriobasurto
  62. 6.11.1 Vittoriobasurto Company Information
  63. 6.11.2 Vittoriobasurto Business Overview
  64. 6.11.3 Vittoriobasurto Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Vittoriobasurto Biomolecule Software Product Portfolio
  66. 6.11.5 Vittoriobasurto Recent Developments
  67. 6.12 SCIEX
  68. 6.12.1 SCIEX Company Information
  69. 6.12.2 SCIEX Business Overview
  70. 6.12.3 SCIEX Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 SCIEX Biomolecule Software Product Portfolio
  72. 6.12.5 SCIEX Recent Developments
  73. 6.13 SoftGenetics, LLC.
  74. 6.13.1 SoftGenetics, LLC. Company Information
  75. 6.13.2 SoftGenetics, LLC. Business Overview
  76. 6.13.3 SoftGenetics, LLC. Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 SoftGenetics, LLC. Biomolecule Software Product Portfolio
  78. 6.13.5 SoftGenetics, LLC. Recent Developments
  79. 6.14 Benchling
  80. 6.14.1 Benchling Company Information
  81. 6.14.2 Benchling Business Overview
  82. 6.14.3 Benchling Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Benchling Biomolecule Software Product Portfolio
  84. 6.14.5 Benchling Recent Developments
  85. 6.15 BioSistemika
  86. 6.15.1 BioSistemika Company Information
  87. 6.15.2 BioSistemika Business Overview
  88. 6.15.3 BioSistemika Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 BioSistemika Biomolecule Software Product Portfolio
  90. 6.15.5 BioSistemika Recent Developments
  91. 6.16 CapitalBio Technology
  92. 6.16.1 CapitalBio Technology Company Information
  93. 6.16.2 CapitalBio Technology Business Overview
  94. 6.16.3 CapitalBio Technology Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 CapitalBio Technology Biomolecule Software Product Portfolio
  96. 6.16.5 CapitalBio Technology Recent Developments
  97. 6.17 cytena GmbH
  98. 6.17.1 cytena GmbH Company Information
  99. 6.17.2 cytena GmbH Business Overview
  100. 6.17.3 cytena GmbH Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 cytena GmbH Biomolecule Software Product Portfolio
  102. 6.17.5 cytena GmbH Recent Developments
  103. 6.18 Eppendorf SE
  104. 6.18.1 Eppendorf SE Company Information
  105. 6.18.2 Eppendorf SE Business Overview
  106. 6.18.3 Eppendorf SE Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 Eppendorf SE Biomolecule Software Product Portfolio
  108. 6.18.5 Eppendorf SE Recent Developments
  109. 6.19 GenomSys
  110. 6.19.1 GenomSys Company Information
  111. 6.19.2 GenomSys Business Overview
  112. 6.19.3 GenomSys Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 GenomSys Biomolecule Software Product Portfolio
  114. 6.19.5 GenomSys Recent Developments
  115. 6.20 Mission Bio
  116. 6.20.1 Mission Bio Company Information
  117. 6.20.2 Mission Bio Business Overview
  118. 6.20.3 Mission Bio Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Mission Bio Biomolecule Software Product Portfolio
  120. 6.20.5 Mission Bio Recent Developments
  121. 6.21 Multid Analyses AB
  122. 6.21.1 Multid Analyses AB Company Information
  123. 6.21.2 Multid Analyses AB Business Overview
  124. 6.21.3 Multid Analyses AB Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Multid Analyses AB Biomolecule Software Product Portfolio
  126. 6.21.5 Multid Analyses AB Recent Developments
  127. 6.22 PhenoSystems SA
  128. 6.22.1 PhenoSystems SA Company Information
  129. 6.22.2 PhenoSystems SA Business Overview
  130. 6.22.3 PhenoSystems SA Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 PhenoSystems SA Biomolecule Software Product Portfolio
  132. 6.22.5 PhenoSystems SA Recent Developments
  133. 6.23 Progenie Molecular
  134. 6.23.1 Progenie Molecular Company Information
  135. 6.23.2 Progenie Molecular Business Overview
  136. 6.23.3 Progenie Molecular Biomolecule Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Progenie Molecular Biomolecule Software Product Portfolio
  138. 6.23.5 Progenie Molecular Recent Developments
7 North America
  1. 7.1 North America Biomolecule Software Market Size (2021-2032)
  2. 7.2 North America Biomolecule Software Market Size by Type
  3. 7.2.1 North America Biomolecule Software Market Size by Type (2021-2026)
  4. 7.2.2 North America Biomolecule Software Market Size by Type (2027-2032)
  5. 7.2.3 North America Biomolecule Software Market Share by Type (2021-2032)
  6. 7.3 North America Biomolecule Software Market Size by Application
  7. 7.3.1 North America Biomolecule Software Market Size by Application (2021-2026)
  8. 7.3.2 North America Biomolecule Software Market Size by Application (2027-2032)
  9. 7.3.3 North America Biomolecule Software Market Share by Application (2021-2032)
  10. 7.4 North America Biomolecule Software Market Size by Country
  11. 7.4.1 North America Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Biomolecule Software Market Size by Country (2021-2026)
  13. 7.4.3 North America Biomolecule Software Market Size by Country (2027-2032)
  14. 7.4.4 North America Biomolecule Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Biomolecule Software Market Size (2021-2032)
  2. 8.2 Europe Biomolecule Software Market Size by Type
  3. 8.2.1 Europe Biomolecule Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe Biomolecule Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe Biomolecule Software Market Share by Type (2021-2032)
  6. 8.3 Europe Biomolecule Software Market Size by Application
  7. 8.3.1 Europe Biomolecule Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe Biomolecule Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe Biomolecule Software Market Share by Application (2021-2032)
  10. 8.4 Europe Biomolecule Software Market Size by Country
  11. 8.4.1 Europe Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Biomolecule Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe Biomolecule Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe Biomolecule Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Biomolecule Software Market Size (2021-2032)
  2. 9.2 China Biomolecule Software Market Size by Type
  3. 9.2.1 China Biomolecule Software Market Size by Type (2021-2026)
  4. 9.2.2 China Biomolecule Software Market Size by Type (2027-2032)
  5. 9.2.3 China Biomolecule Software Market Share by Type (2021-2032)
  6. 9.3 China Biomolecule Software Market Size by Application
  7. 9.3.1 China Biomolecule Software Market Size by Application (2021-2026)
  8. 9.3.2 China Biomolecule Software Market Size by Application (2027-2032)
  9. 9.3.3 China Biomolecule Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Biomolecule Software Market Size (2021-2032)
  2. 10.2 Asia Biomolecule Software Market Size by Type
  3. 10.2.1 Asia Biomolecule Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia Biomolecule Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia Biomolecule Software Market Share by Type (2021-2032)
  6. 10.3 Asia Biomolecule Software Market Size by Application
  7. 10.3.1 Asia Biomolecule Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia Biomolecule Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia Biomolecule Software Market Share by Application (2021-2032)
  10. 10.4 Asia Biomolecule Software Market Size by Country
  11. 10.4.1 Asia Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Biomolecule Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia Biomolecule Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia Biomolecule Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Biomolecule Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Biomolecule Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Biomolecule Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Biomolecule Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Biomolecule Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Biomolecule Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Biomolecule Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Biomolecule Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Biomolecule Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Biomolecule Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Biomolecule Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Biomolecule Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Biomolecule Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Biomolecule Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst